Massachusetts General — Boston, Massachusetts

Massachusetts General is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General has participated in 14 clinical trials with 5 currently active.

Therapeutic areas: Thoracic Aortic Disease, Acute Respiratory Tract Infections, Leiomyosarcoma.

Sponsors: Ottawa Heart Institute Research Corporation, Rapid Pathogen Screening, Sarcoma Alliance for Research through Collaboration.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General?

Massachusetts General has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General conducted?

Massachusetts General has 14 clinical trials on record, with 5 currently active. Their work covers Thoracic Aortic Disease, Acute Respiratory Tract Infections, Leiomyosarcoma.

Is Massachusetts General accredited by Crixeo Health?

Yes — Massachusetts General holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Massachusetts General?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.